A 52-year-old man from Mumbai presents with a 3 mm thick, ulcerated melanoma on the dorsal forearm with no clinically palpable lymph nodes. Sentinel lymph node biopsy is negative. Which AJCC 8th edition stage best describes this lesion, and what is the most important prognostic discriminator from a Stage IIIA melanoma?

Question

Accepted Answer

A. Stage IIB; the absence of lymph node involvement distinguishes it from Stage IIIA. ## AJCC 8th Edition Staging: Stage IIC vs Stage IIIA

### Clinical Scenario Analysis

**Key Point:** A 3 mm **ulcerated** melanoma with **negative** sentinel lymph node biopsy is classified as **T3b N0 M0 = Stage IIC** per AJCC 8th edition. The presence of ulceration in a T3 lesion (1.01–4.0 mm) is what defines T3b, and T3b N0 M0 maps to **Stage IIC** — not Stage IIB. Stage IIIA requires nodal micrometastases (N1a or N2a), which are absent here.

### TNM Breakdown for This Case

| Component | This Case | Stage IIC Criterion | Stage IIIA Criterion |
|-----------|-----------|-------------------|--------------------|
| **T (Thickness)** | 3 mm | T3b or T4b | T1a–T4b |
| **U (Ulceration)** | Present | Required (b suffix) | Yes or No |
| **N (Nodes)** | Negative (N0) | N0 | N1a/N2a (micrometastases) |
| **M (Metastasis)** | Absent | M0 | M0 |
| **Stage** | **IIC** | ✓ | — |

### AJCC 8th Edition Stage II Hierarchy (High-Yield)

**High-Yield:** In AJCC 8th edition, Stage II substages are defined as follows:
- **Stage IIA:** T2b N0 M0 or T3a N0 M0 (ulcerated T2 or non-ulcerated T3)
- **Stage IIB:** T3b N0 M0 or T4a N0 M0 — **Wait:** T3b N0 M0 is actually **Stage IIC** in AJCC 8th edition
- **Stage IIC:** T3b N0 M0 or T4b N0 M0 (ulcerated T3 or ulcerated T4)

> **Critical correction:** In AJCC 8th edition (unlike 7th edition), **T3b N0 M0 = Stage IIC**, not Stage IIB. Stage IIB corresponds to T3b/T4a in the 7th edition but was reclassified in the 8th edition. T3b N0 M0 → Stage IIC; T4b N0 M0 → Stage IIC.

### Why Ulceration Is the Key Discriminator from Stage IIIA

**Clinical Pearl:** The most important prognostic discriminator between Stage IIC and Stage IIIA is the **presence of ulceration without nodal involvement** (IIC) versus **nodal micrometastases without ulceration requirement** (IIIA). Notably, Stage IIC melanoma (T3b/T4b N0 M0) has a **worse 5-year survival (~82%)** than Stage IIIA (~93%), reflecting the powerful negative prognostic impact of ulceration.

### Why Other Options Are Wrong

1. **Option B (Stage IIB):** Incorrect staging — T3b N0 M0 is Stage IIC in AJCC 8th edition, not IIB.
2. **Option C:** Incorrectly labels this as Stage IIB and misidentifies the T3b → IIB mapping.
3. **Option D:** Thickness alone never auto-upgrades to Stage III; nodal involvement is required.

### Mnemonic

**Mnemonic:** **"Ulceration Ups the Stage"** — in AJCC 8th edition, ulceration in T3 (T3b) places the patient in Stage IIC, which paradoxically has worse prognosis than Stage IIIA (1 micrometastasis). This is a classic NEET PG trap.

*Reference: AJCC Cancer Staging Manual, 8th Edition, Chapter 47 (Melanoma of the Skin); Gershenwald JE et al., CA Cancer J Clin 2017.*

Answer

B. Stage IIC; the presence of ulceration distinguishes it from Stage IIIA

Answer

C. Stage IIIA; the thickness >2 mm automatically upgrades to Stage III regardless of lymph node status

Answer

D. Stage IIB; ulceration in a T3 lesion (1.01–4.0 mm) without nodal disease is the key difference from Stage IIIA

Explanation

Practice similar questions